Broadpoint Downgrades Express Scripts (ESRX) to Buy
More News related to ESRX
- Stifel Nicolaus Initiates Coverage on Express Scripts (ESRX) with a Hold
- UBS Starts Numerous Healthcare Stocks: CAH, MCK, ESRX at Buy, PMC, OCR at Neutral
- InvestorSoup.com issues Technical Trading Outlook for Health Sciences Group Inc.
- Griffin's Blue Ridge Likes A Major Bank, Swaps Into Gold Miner ETF, Picks Up More Silver and Makes Moves In Tech
- Express Scripts to Build High Volume Filler Pharmacy in St. Louis
More News related to Downgrades
- Wunderlich Securities Downgrades Gran Tierra Energy (GTE) to Hold
- Stephens Downgrades Benihana (BNHN) to Equalweight
- UBS Downgrades NRG Energy (NRG) to Neutral; Cuts Target to $26
- Citi Cuts Lukoil (LUKOY) to Hold
Broadpoint Capital downgrades Express Scripts (Nasdaq: ESRX) from Strong Buy to Buy.
Express Scripts, Inc. provides a range of pharmacy benefit management services in North America.
Related Categories
DowngradesStocks Mentioned
-1.20Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
